Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • YK5 is a novel dual Hsc/Hsp70 inhibitor that is selective for tumor Hsp70 and is a valuable lead for the development of molecules with therapeutic potential in breast cancer
    Meeting Abstract

    Taldone, Tony; Kang, Yanlong; Rodina, Anna; Maharaj, Ronnie; Gozman, Alexander; Cerchietti, Leandro; Wong, Michael J. H.; Baaklini, Imad; Caldas Lopes, Eloisi; Patel, Hardik J.; more...
    Abstracts of Papers of the American Chemical Society (2011)

    Fulltext@MSK | Save
  • Donor kir2ds1 and kir3ds1 are associated with improved outcomes following unrelated allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Venstrom, J. M.; Pittari, G.; Chewning, J.; Gooley, T. A.; Spellman, S.; Haagenson, M.; Gallagher, M. M.; Malkki, M.; Petersdorf, E.; Dupont, B.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • KIR-HLA genotypes have no identifiable role in unit predominance following double unit cord blood transplantation
    Meeting Abstract

    Tarek, N.; Gallagher, M. M.; Chou, J. F.; Lubin, M. N.; Heller, G.; Barker, J. N.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Normally hyporesponsive unlicensed natural killer cells are stronglyactivated by neuroblastoma (Nb) in the presence of anti-gd2 monoclonal antibody (MoAb)
    Meeting Abstract

    Tarek, N.; Gallagher, M.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • 124I-PUH71 PET detects upregulated HSP90 breast cancer xenografts
    Meeting Abstract

    Roney, C. A.; Pillarsetty, K.; Caldas-Lopes, E.; Taldone, T.; Chiosis, G.; Lewis, J. S.
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • A pilot study of T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M.; Chung, D. J.; Young, J. W.; Giralt, S.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • CARs on track in the clinic
    Journal Article

    Kohn, D. B.; Dotti, G.; Brentjens, R.; Savoldo, B.; Jensen, M.; Cooper, L. J. N.; June, C. H.; Rosenberg, S.; Sadelain, M.; Heslop, H. E.
    Molecular Therapy (2011)

    Fulltext@MSK | Save
  • Universal role for hla-c and kir2dl ligand mismatch in severe acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation (u-hsct) in Japanese and Caucasian transplant recipients: An analysis on behalf of international histocompatibility working group in hematopoietic cell transplantation
    Meeting Abstract

    Kawase, T.; Morishima, Y.; Malkki, M.; Gooley, T. A.; Hsu, K. C.; Dupont, B.; Bardy, P.; Madigral, A.; Bignon, J. D.; Spellman, S.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Genetically engineered donor T cells for BMT immunotherapy: Expression of trail and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save